Cincinnati Children’s recently installed the Aquilion ONE program to perform a number of examinations, including trauma, cancer, human brain perfusion, cardiac function exams and routine CT imaging. Many children’s hospitals, including Cincinnati Children’s, strive to meet the ALARA principle of radiation. The Aquilion ONE helps these hospitals attain these high criteria in imaging. The software uses protocols predicated on the patient’s age group and size, and type of exam, to make sure patients receive only rays required to obtain a clear diagnostic picture. SUREExposure Pediatric software comes regular on all Aquilion items. Related StoriesLow-dose occupational radiation exposure raises solid cancer riskLatest analysis on thyroid malignancy to become highlighted at 15th International Thyroid CongressImaging studies required to diagnose traumatic injuries in pregnant women can be secure when used properlyIn addition to SUREExposure Pediatric, the Aquilion ONE is available with a Pediatric Kit that includes child-friendly add-ons and features, including: iStation, an audio-visual instructional device to help kids maintain breath-hold during exams by displaying animated films specially designed to teach them when to hold their breath and unwind them through the exam Colorful designs and pictures on the Aquilion ONE’s exterior, creating a far more visually compelling and child-friendly looking program Pediatric accessories, such as child-size table straps and infant cushion, to provide a stable, comfortable examination for pediatric individuals of most sizes A smaller look-alike of the Aquilion ONE, allowing children to connect to the CT to understand even more about the imaging procedure and alleviate fear about the examination ‘Toshiba recognizes that children have different imaging requirements than adults and that limiting radiation and sedation is crucial for safe pediatric exams,’ said Doug Ryan, vice president, Marketing and Strategic Development, Toshiba.Related StoriesNew RNA test of blood platelets may be used to detect area of cancerViralytics enters into medical trial collaboration contract with MSDOvarian cancer patients with a brief history of oral contraceptive make use of have better outcomesThe researchers reported that SAHA triggered no adverse effects in the animals at the dosages given. Mishra stated he hoped to start out a phase I medical trial of SAHA in lupus sufferers next year. Phase I studies are primarily worried about assessing a drug’s safety. Mishra said it would be a double blind study, where neither doctor nor individual will know whether they received SAHA or an inert placebo before end of the study.